Thus, these results suggest that COS possesses the ability to suppress the activation of microglial mTOR/NF-κB/IL-1β pathway in order to alleviate neuroinflammation and restore AHN deficits induced by CRS. This evidence concerns the gene NFKB1 and congenital rubella syndrome.